• A deal undone: Biocon, Pfizer go back on alliance
• Budget disappoints India biotech industry
• PPP: Energy security with biofuels
  • Mission: Economical way to bioethanol
  • Mission: Disease-free Jatropha hybrids
  • Mission: High yielding Jatropha for biodiesel
• Innovation-driven research
  • Targeting four pathways of TB (Dr Dinakar M Salunke, executive director, Regional Center for Biotechnology, Gurgaon)
  • IPCA's guide in drug discovery (Dr Ashok Kumar, president- Center for R&D, IPCA Labs)
  • Innovation in contract research (Dr Ganesh Sambasivam, CSO, Anthem Biosciences)
• Scotland woos biotech companies

BioTalk

'We are looking at 400% growth' - Dr B V Ravi Kumar, founder chairman and MD, XCyton Diagnostics

'We have a strong and diversified pipeline of novel targets' - Dr Suri Venkatchalam, CEO, Connexios Life Sciences

BioComment

CROs on budget blind spot

BioPolicy

India to control FMD in cattle

BioAnalysis

India allows compulsory licensing of Bayer

BioServices

'We provide services to 14 of the top 20 pharma companies' - Mr Swapan Bhattacharya, MD,TCG Life Sciences

BioSupplier

'Our plan is further growth in classical pharmaceuticals' - Mr M S Mahadevan, CEO, Biozeen

'Third generation sequencing is superior to NGS' - Mr Neeraj Gupta, director - sales & marketing, Imperial Life Sciences, Gurgaon

About BioSpectrum | Feedback | Contact Us | jobs@Cybermedia